CAPR
Price
$6.34
Change
-$0.63 (-9.04%)
Updated
May 9 closing price
Capitalization
289.59M
2 days until earnings call
RANI
Price
$0.73
Change
-$0.05 (-6.41%)
Updated
May 9 closing price
Capitalization
24.51M
One day until earnings call
Ad is loading...

CAPR vs RANI

Header iconCAPR vs RANI Comparison
Open Charts CAPR vs RANIBanner chart's image
Capricor Therapeutics
Price$6.34
Change-$0.63 (-9.04%)
Volume$3.64M
Capitalization289.59M
Rani Therapeutics Holdings
Price$0.73
Change-$0.05 (-6.41%)
Volume$387.75K
Capitalization24.51M
CAPR vs RANI Comparison Chart
Loading...
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAPR vs. RANI commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAPR is a Hold and RANI is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (CAPR: $6.34 vs. RANI: $0.73)
Brand notoriety: CAPR and RANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CAPR: 199% vs. RANI: 205%
Market capitalization -- CAPR: $289.59M vs. RANI: $24.51M
CAPR [@Biotechnology] is valued at $289.59M. RANI’s [@Biotechnology] market capitalization is $24.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAPR’s FA Score shows that 0 FA rating(s) are green whileRANI’s FA Score has 0 green FA rating(s).

  • CAPR’s FA Score: 0 green, 5 red.
  • RANI’s FA Score: 0 green, 5 red.
According to our system of comparison, CAPR is a better buy in the long-term than RANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAPR’s TA Score shows that 4 TA indicator(s) are bullish while RANI’s TA Score has 4 bullish TA indicator(s).

  • CAPR’s TA Score: 4 bullish, 7 bearish.
  • RANI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RANI is a better buy in the short-term than CAPR.

Price Growth

CAPR (@Biotechnology) experienced а -46.54% price change this week, while RANI (@Biotechnology) price change was -32.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

CAPR is expected to report earnings on Aug 07, 2025.

RANI is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAPR($290M) has a higher market cap than RANI($24.5M). RANI YTD gains are higher at: -46.715 vs. CAPR (-54.058). CAPR has higher annual earnings (EBITDA): -34.79M vs. RANI (-48.72M). CAPR has more cash in the bank: 85M vs. RANI (30.4M). CAPR has less debt than RANI: CAPR (1.65M) vs RANI (33.7M). CAPR has higher revenues than RANI: CAPR (23.2M) vs RANI (0).
CAPRRANICAPR / RANI
Capitalization290M24.5M1,184%
EBITDA-34.79M-48.72M71%
Gain YTD-54.058-46.715116%
P/E RatioN/AN/A-
Revenue23.2M0-
Total Cash85M30.4M280%
Total Debt1.65M33.7M5%
FUNDAMENTALS RATINGS
CAPR: Fundamental Ratings
CAPR
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
71
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CAPRRANI
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 19 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BSGIX15.590.07
+0.45%
Baird Small/Mid Cap Growth Institutional
FESAX9.360.01
+0.11%
First Eagle Small Cap Opportunity A
HEQFX4.55N/A
N/A
Monteagle Opportunity Equity Inv
MRGHX48.88-0.07
-0.14%
MFS Core Equity R3
GFFDX79.48-0.17
-0.21%
Invesco Global Focus R5